Suchergebnisse - "Takayama, Tadatoshi"

PubPharm (43)

1

Arterial chemoembolisation with cisplatin versus epirubicin for hepatocellular carcinoma (ACE 500 study) : A multicentre, randomised controlled phase 2/3 trial

enthalten in: European journal of cancer (Oxford, England : 1990) | 2021

von Aramaki, O. | Takayama, T. | Moriguchi, M. | +12

2

Analysis of Patient Outcome after Non-curative Resection for Hepatocellular Carcinoma Using Nationwide Survey Data in Japan

enthalten in: World journal of surgery | 2021

von Aoki, T. | Kubota, K. | Kubo, S. | +10

3

Comparison of the surgical outcomes in patients with synchronous versus metachronous multiple hepatocellular carcinoma

enthalten in: Bioscience trends | 2021

von Midorikawa, Y. | Takayama, T. | Higaki, T. | +5

4

Subcuticular sutures reduce surgical site infection after repeat liver resection : a matched cohort analysis

enthalten in: Bioscience trends | 2021

von Yamazaki, S. | Takayama, T. | Matsuno, Y. | +4

5

Six autoantibodies as potential serum biomarkers of hepatocellular carcinoma : A prospective multicenter study

enthalten in: International journal of cancer | 2020

von Okada, R. | Otsuka, Y. | Wakabayashi, T. | +12

6

High C-reactive protein/albumin ratio associated with reduced survival due to advanced stage of intrahepatic cholangiocarcinoma

enthalten in: Bioscience trends | 2020

von Kano, H. | Midorikawa, Y. | Song, P. | +5

7

Comparison of Short-Term Outcomes Between Hand-assisted Laparoscopic Distal Gastrectomy and Laparoscopy-assisted Distal Gastrectomy in Gastric Cancer

enthalten in: Surgical laparoscopy, endoscopy & percutaneous techniques | 2020

von Hagiwara, K. | Matsuda, M. | Hayashi, S. | +3

8

Liver Resection Versus Embolization for Recurrent Hepatocellular Carcinoma

enthalten in: World journal of surgery | 2020

von Midorikawa, Y. | Takayama, T. | Moriguchi, M. | +7

9

Treatment Optimization for Hepatocellular Carcinoma in Elderly Patients in a Japanese Nationwide Cohort

enthalten in: Annals of surgery | 2019

von Kaibori, M. | Yoshii, K. | Hasegawa, K. | +13

10

Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial

enthalten in: Gut | 2019

von Pinyol, R. | Montal, R. | Bassaganyas, L. | +27

1
2
3
4
5
Nächster »
[5]